GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Public ClinicalTrials.gov record NCT03700047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.
Study identification
- NCT ID
- NCT03700047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2018 (Actual)
- Primary completion
- Jun 10, 2019 (Actual)
- Completion
- May 22, 2020 (Actual)
- Last update posted
- Aug 26, 2022
2018 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Study site | Los Angeles | California | 90069 | — |
| Galderma Study Site | Sacramento | California | 95816 | — |
| Galderma Study Site | Solana Beach | California | 92075 | — |
| Galderma Study Site | Miami | Florida | 11137 | — |
| Galderma Study Site | West Palm Beach | Florida | 33401 | — |
| Galderma Study Site | New Orleans | Louisiana | 70115 | — |
| Galderma Study Site | Baltimore | Maryland | 21208 | — |
| Galderma Study Site | Chestnut Hill | Massachusetts | 02467 | — |
| Galderma Study Site | Mount Kisco | New York | 10549 | — |
| Galderma Study Site | New York | New York | 10021 | — |
| Galderma Study Site | New York | New York | 10028 | — |
| Galderma study site | Charleston | South Carolina | 29414 | — |
| Galderma study site | Bellaire | Texas | 77401 | — |
| Galderma Study site | Dallas | Texas | 75254 | — |
| Galderma Study Site | Salt Lake City | Utah | 84101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03700047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03700047 live on ClinicalTrials.gov.